An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia.
Schizophrenic women have been consistently found to have a later age of onset and a less severe clinical course of illness as compared with schizophrenic men. Because these differences are not explained by diagnostic artifacts or sociocultural factors, we tested the hypothesis that they are determined by the influence of the gonadal hormones testosterone and estradiol on dopaminergic (DA) neurotransmission. We used animal models in which the effects of the hormones on behavioral changes induced by the DA antagonist haloperidol (catalepsy) and by the DA agonist apomorphine (oral stereotypies, grooming and sitting behavior) were investigated in neonatal and in adult treated rats. No consistent effects of testosterone were observed. Estradiol significantly reduced the behavioral changes induced by both haloperidol and apomorphine, and this effect was more pronounced in neonatally treated animals. These results suggest a downward regulation of DA neurotransmission by estradiol, which is supported by the results of 3H-sulpiride binding determinations in brain homogenates from the same animals: estradiol caused a 2.8-fold reduction of DA receptor affinity to sulpiride. Our findings suggest that estradiol might act as a protective modulator in schizophrenia by enhancing the vulnerability threshold for psychosis through the downward regulation of DA neurotransmission. Such mechanism could explain, at least in part, the later onset and the more favorable course of schizophrenia in female patients.
Häfner
H
H
Psychiatric Clinic, Central Institute of Mental Health, Mannheim, Germany.
Behrens
S
S
De Vry
J
J
Gattaz
W F
WF
D000367:Age Factors; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced; D004958:Estradiol / Q000096:biosynthesis*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism*; D012737:Sex Factors; D013739:Testosterone / Q000378:metabolism*
D011954:Receptors, Dopamine; D013739:Testosterone; D004958:Estradiol; D006220:Haloperidol; D001058:Apomorphine